Publication Year

Hooda N, Svane HML, Fryzek J, Nicoholson G, White JB, Edris B, Smith LM, Petersen MM, Baad-Hansen T, Keller JØ, Jørgensen PH, Pedersen AB. The epidemiology of desmoid tumors in Denmark. Poster presented at the Connective Tissue Oncology Society Annual Meeting, November 2021.

Thompson CM, Aardema MJ, Heintz MM, MacGregor JT, Young RR. 2021. A review of mammalian in vivo genotoxicity of hexavalent chromium: Implications for oral carcinogenicity risk assessment. Crit Rev Toxicol 51(10)820-849; doi: 10.1080/10408444.2021.2000934. PMID: 35060824.

Black MB, Andersen ME, Pendse SN, Borghoff SJ, Streicker M, McMullen PD. 2021. RNA-sequencing (transcriptomic) data collected in liver and lung of male and female B6C3F1 mice exposed to various dose levels of 4-methylimidazole for 2, 5, or 28 days. Data in Brief 38(Oct):107420; doi: 10.1016/j.dib.2021.107420. PMID: 34660856.

Palermo CM, Foreman JE, Wikoff DS, Lea I. 2021. Development of a putative adverse outcome pathway network for male rat reproductive tract abnormalities with specific considerations for the androgen sensitive window of development. Curr Res Toxicol 2(July 22):254–271; doi: 10.1016/j.crtox.2021.07.002. PMID: 34401750.

Gentry R, Rodricks J, Clewell H, Greene T, Chappell G, Lea I, Borghoff S, Yang C, Rathman J, Ribeiro JV, Hobocienski B, Mostrag A. 2021. RE: Response to the Office of Environmental Health Hazard Assessment on comments related to Gentry et al. (2021). Food Chem Toxicol 152(June):112202; doi: 10.1016/j.fct.2021.112202. PMID: 33872725.

Gentry R, Greene T, Chappell G, Lea I, Borghoff S, Yang C, Rathman J, Ribeiro JV, Hobocienski B, Mostrag A, Rodricks J, Clewell H. 2021. Integration of evidence to evaluate the potential for neurobehavioral effects following exposure to USFDA-approved food colors. Food Chem Toxicol 151(May):112097; doi: 10.1016/j.fct.2021.112097. PMID: 33677041.

Lea IA, Chappell GA, Wikoff DS. 2021. Overall lack of genotoxic activity among five common low- and no-calorie sweeteners: A contemporary review of the collective evidence. Mutat Res Genet Toxicol Environ Mutagen 868–869(Aug-Sept):503389; doi: 10.1016/j.mrgentox.2021.503389. PMID: 34454695.

Patlewicz G, Dean J, Gibbons C, Judson R, Keshava N, Vegosen L, Martin T, Pradeep P, et al. 2021. Integrating publicly available information to screen potential candidates for chemical prioritization under the Toxic Substances Control Act: A proof of concept case study using genotoxicity and carcinogenicity. Comput Toxicol 20(Nov):100185; doi: 10.1016/j.comtox.2021.100185. PMID: 35128218.

Huang M, Gedansky A, Hassett CE, Price C, Fan TH, Stephens RS, et al. 2021. Pathophysiology of brain injury and neurological outcome in acute respiratory distress syndrome: A scoping review of preclinical to clinical studies. Neurocrit Care 35(2):518–527; doi: 10.1007/s12028-021-01309-x.

Erber L, Goodman S, Jokipii Krueger CC, Rusyn I, Tretyakova N. 2021. Quantitative nanoLC/NSI⁺-HRMS method for 1,3-butadiene induced bis-N7-guanine DNA-DNA cross-links in urine. Toxics 9(10):247; doi: 10.3390/toxics9100247. PMID: 34678943.

Heintz MM, Doepker CL, Wikoff DS, Hawks SE. 2021. Assessing the food safety risk of ochratoxin A in coffee: A toxicology-based approach to food safety planning. J Food Sci 86(11):4799-4810; doi: 10.1111/1750-3841.15938.

Shah I, Tate T, Patlewicz G. 2021. Generalized Read-Across prediction using genra-py. Bioinformatics 37(19):3380-3381; doi: 10.1093/bioinformatics/btab210. PMID: 33772575.

Feuerstadt P, Boules M, Stong L, Dahdal DN, Sacks NC, Lang K, Nelson WW. 2021. Clinical complications in patients with primary and recurrent Clostridioides difficile infection: A real-world data analysis. SAGE Open Med 9:2050312120986733; doi: 10.1177/2050312120986733. PMID: 33505698.

Wright PSR, Briggs KA, Thomas R, Smith GF, Maglennon G, Mikulskis P, Chapman M, Greene N, Bender A. The impact of pooling animal histopathology control data on the statistical detection of treatment-related findings. Abstract SOC02-05, 56^th Congress of the European Societies of Toxicology (EUROTOX 2021). Toxicol Lett 350(Sup):S63; doi: 10.1016/S0378-4274(21)00395-7, 2021.

Hackshaw A, Cohen SS, Reichert H, Kansal AR, Chung KC, Ofman JJ. 2021. Estimating the population health impact of a multi-cancer early detection genomic blood test to complement existing screening in the US and UK. Brit J Cancer 125(10):1432-1442; doi: 10.1038/s41416-021-01498-4. PMID: 34426664.

Migdady I, Stephens RS, Price C, Geocadin RG, Whitman G, Cho SM. 2021. The use of apnea test and brain death determination in patients on extracorporeal membrane oxygenation: A systematic review. J Thorac Cardiovasc Surg 162(3):P867-P877; https://doi.org/10.1016/j.jtcvs.2020.03.038.

Moran KR, Dunson D, Wheeler MW, Herring AH. 2021. Bayesian joint modeling of chemical structure and dose response curves. Ann Appl Stat 15(3):1405; doi: 10.214/21-aoas1461. PMCID: PMC9236276.

McGrath LJ, Nielson C, Saul B, Breskin A, Yu Y, Nicolaisen SK, … Kelsh M, et al. 2021. Lessons learned using real-world data to emulate randomized trials: A case study of treatment effectiveness for newly diagnosed immune thrombocytopenia. Clin Pharmacol Ther 110(6):1570–1578; doi: 10.1002/cpt.2399. PMID: 34416023.

Hathway J, Miller-Wilson L, Sharma A, Jensen I, Yao W, Raza S, et al. 2021. The impact of increasing multitarget stool DNA use among colorectal cancer screeners in a self-insured US employer population. J Mark Access Health Policy, 9(1):1948670; doi: 10.1080/20016689.2021.1948670.